Christine Cournoyer
Known title: DirectorCIK: 0001180466
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
CareDx shows high growth and fair‑value boost after reimbursement news. Recent coverage noted CareDx’s strong revenue growth and improving fundamentals. Analyst updates cited new reimbursement information and target revisions, leading to a modest fair‑value increase. The company’s performance appears to be gaining attention among investors.
Transaction History
| SPOK | ▲ Buy | Grant | 2,383 | $25K | 10/1/2026 | View on chart |
| SPOK | ▼ Sell | Open Market | 8,320 | $94K | 8/10/2026 | View on chart |
| CDNA | ▼ Sell | Open Market | 16,000 | $751K | 8/4/2026 | View on chart |
| SPOK | ▲ Buy | Grant | 2,441 | $25K | 7/1/2026 | View on chart |
| CDNA | ▲ Buy | Grant | 9,795 | $0 | 6/12/2026 | View on chart |
| SPOK | ▲ Buy | Grant | 2,294 | $25K | 4/1/2026 | View on chart |
| SPOK | ▲ Buy | Grant | 1,895 | $25K | 1/2/2026 | View on chart |
| SPOK | ▲ Buy | Grant | 1,449 | $25K | 10/1/2025 | View on chart |
| SPOK | ▲ Buy | Grant | 1,414 | $25K | 7/1/2025 | View on chart |
| CDNA | ▲ Buy | Grant | 12,103 | $0 | 6/13/2025 | View on chart |
| CDNA | ▲ Buy | Option Exercise | 29,136 | $232K | 5/12/2025 | View on chart |
| CDNA | ▼ Sell | Open Market | 29,136 | $465K | 5/12/2025 | View on chart |
| SPOK | ▼ Sell | Open Market | 5,000 | $82K | 5/9/2025 | View on chart |
| CDNA | ▼ Sell | Open Market | 16,700 | $236K | 5/6/2025 | View on chart |
| SPOK | ▲ Buy | Grant | 1,521 | $25K | 4/1/2025 | View on chart |
| SPOK | ▼ Sell | Open Market | 12,000 | $198K | 3/4/2025 | View on chart |
| SPOK | ▲ Buy | Grant | 1,558 | $25K | 1/2/2025 | View on chart |
| SPOK | ▲ Buy | Grant | 1,660 | $25K | 10/1/2024 | View on chart |
| SPOK | ▲ Buy | Grant | 1,688 | $25K | 7/1/2024 | View on chart |
| CDNA | ▲ Buy | Grant | 10,570 | $0 | 6/14/2024 | View on chart |
| SPOK | ▲ Buy | Grant | 1,567 | $25K | 4/1/2024 | View on chart |
| CDNA | ▲ Buy | Grant | 2,288 | $0 | 1/4/2024 | View on chart |
| SPOK | ▲ Buy | Grant | 1,615 | $25K | 1/2/2024 | View on chart |
| CDNA | ▲ Buy | Grant | 1,552 | $0 | 10/4/2023 | View on chart |
| SPOK | ▲ Buy | Grant | 1,752 | $25K | 10/2/2023 | View on chart |
| SPOK | ▲ Buy | Grant | 1,129 | $15K | 7/3/2023 | View on chart |
| CDNA | ▲ Buy | Grant | 18,844 | $0 | 6/16/2023 | View on chart |
| SPOK | ▲ Buy | Grant | 1,481 | $15K | 4/3/2023 | View on chart |
| SPOK | ▲ Buy | Grant | 1,832 | $15K | 1/3/2023 | View on chart |
| CDNA | ▲ Buy | Grant | 775 | $0 | 10/4/2022 | View on chart |
| SPOK | ▲ Buy | Grant | 1,963 | $15K | 10/3/2022 | View on chart |
| CDNA | ▲ Buy | Grant | 397 | $0 | 7/1/2022 | View on chart |
| CDNA | ▲ Buy | Grant | 4,863 | $0 | 6/16/2022 | View on chart |
| CDNA | ▲ Buy | Grant | 100 | $2K | 5/9/2022 | View on chart |
| CDNA | ▲ Buy | Grant | 352 | $0 | 4/1/2022 | View on chart |
| CDNA | ▲ Buy | Grant | 263 | $0 | 1/3/2022 | View on chart |
| SPOK | ▲ Buy | Grant | 1,468 | $15K | 10/1/2021 | View on chart |
| CDNA | ▲ Buy | Grant | 180 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Spok Holdings supports hospitals on U.S. News Best Children's Hospitals list
Spok Holdings announced that its technology supports all leading hospitals named to the U.S. News & World Report 2026-2027 Best Children's Hospitals Honor Roll. This highlights the company's role in the healthcare sector by serving top-tier medical institutions. The news serves as a brand endorsement for Spok's digital health solutions within the pediatric care market.
Spok Holdings supports hospitals on U.S. News Best Children's Hospitals list. Spok Holdings announced that its technology supports all leading hospitals named to the U.S. News & World Report 2026-2027 Best Children's Hospitals Honor Roll. This highlights the company's role in the healthcare sector by serving top-tier medical institutions. The news serves as a brand endorsement for Spok's digital health solutions within the pediatric care market.